Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Breast cancer
2019 Standout
Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update
2015
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Expanding global access to radiotherapy
2015 Standout
Dendritic Cells: Translating Innate to Adaptive Immunity
2006 StandoutNobel
Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells
2008 StandoutNobel
The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer
2006
Breast cancer
2016 Standout
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
2015
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
2012
Imaging in the era of molecular oncology
2008 StandoutNature
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
2013
Nasopharyngeal carcinoma
2019 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation
2012
A review of methods of analysis in contouring studies for radiation oncology
2010
Molecular markers predicting radiotherapy response: Report and recommendations from an International Atomic Energy Agency technical meeting
2005
Fcγ receptors as regulators of immune responses
2007 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
2010 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
2005
Influence of connective tissue diseases on the expression of radiation side effects: A systematic review
2006
Radiomics: the process and the challenges
2012 Standout
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
High-tech in radiation oncology: should there be a ceiling?
2004
Nasopharyngeal carcinoma
2015 Standout
FDG-PET,a Complementary Modality to Computed Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer
2012
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas
2011
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Quality Indicators for Breast Cancer: Revisiting Historical Evidence in the Context of Technology Changes
2011
Dosimetry audit for a multi-centre IMRT head and neck trial
2009
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
New Radiation Therapy Techniques for the Treatment of Head and Neck Cancer
2005
Feasibility and Efficacy of Accelerated Weekly Concomitant Boost Postoperative Radiation Therapy Combined with Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer
2009
Direct targeting of genetically modified tumour cells to FcγRI triggers potent tumour cytotoxicity
2005
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
2012
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes
2007
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
2005
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Imaging and cancer: A review
2008
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Tensor Regression with Applications in Neuroimaging Data Analysis
2013 Standout
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
2007
Head and Neck Cancer
2020 Standout
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Breast Cancer Treatment
2019 Standout
PET-based treatment planning in radiotherapy: a new standard?
2007
Concurrent Chemoradiotherapy for Locally Advanced, Nonmetastatic, Squamous Carcinoma of the Head and Neck: Consensus, Controversy, and Conundrum
2006
18F-FDG PET/CT Imaging In Oncology
2011
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
2014
FDG-PET and Beyond: Molecular Breast Cancer Imaging
2005
Works of J.B. Davis being referenced
Quality Assurance in the EORTC Randomized Trial 22922/10925 Investigating the Role of Irradiation of the Internal Mammary and Medial Supraclavicular Lymph Node Chain Works
2006
Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer
2000
Quality assurance in the EORTC phase III randomised ‘boost vs. no boost’ trial for breast conserving therapy: Comparison of the results of two individual case reviews performed early and late during the accrual period
2005
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study
2003
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning
2010
Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary—medial supraclavicular irradiation in stage I-III breast cancer: the individual case review
2003
The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future
2005
Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run
2002
[18FDG] PET-CT-Based Intensity-Modulated Radiotherapy Treatment Planning of Head and Neck Cancer
2007
Automated functional image-guided radiation treatment planning for rectal cancer
2005
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review
2008
Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy
2004